Skip to content

Sichenzia Ross Friedman Ference LLP Represents Sole-Book Running Manager in $3.0M Public Offering for CollabRX

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. as Sole Book-Running Manager on $5.52M Public Offering of CollabRX, Inc.

Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. on a $20.0 Million Public Offering of Actinium Pharmaceuticals, Inc.

Sichenzia Ross Friedman Ference LLP Advises Trovagene Inc. on a $23.0M Public Offering

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $28.7M Public Offering

Full Swing Golf Announces Endorsement Deal with Tiger Woods

Vuzix Corp. Announces $24.8M Investment from Intel

PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

SBI Investments Announces $6.5 Million Private Placement

Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

Synergy Pharmaceuticals Inc. Raises $200M Rule 144A Offering of 7.50% Convertible Senior Notes

Sichenzia Ross Friedman Ference Advises MV Agusta on Partnership with Mercedes-AMG

ContraVir Pharmaceuticals Announces $9.0 Million Private Placement

CEL-SCI Corporation Announces $6.0 Million Public Offering

Towerstream Corporation Announces $35.0 Million Secured Financing

Sichenzia Ross Friedman Ference LLP Advises Single Touch on a $11.0 M Debt and Equity Financing Consisting of a $10.0 M Secured Financing and a $1.0 M PIPE with Fortress Investment Group

Sichenzia Ross Friedman Ference LLP Advises Rightscorp, Inc. on a $2.65M PIPE Offering

Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on a Reverse Merger and $2.04 Million Pipe Financing

Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock.

Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering

Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering